Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

Overview of attention for article published in BMC Cancer, December 2012
Altmetric Badge

About this score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#21 of 2,597)
  • High score compared to outputs of the same age (95th percentile)
  • High score compared to outputs of the same age and source (99th percentile)

Mentioned by

blogs
1 blog
twitter
20 tweeters
facebook
2 Facebook pages

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this scholarly content. Click here to find out more.
Title
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial
Published in
BMC Cancer, December 2012
DOI 10.1186/1471-2407-12-603
Pubmed ID
Authors

Pérol D, Provençal J, Hardy-Bessard AC, Coeffic D, Jacquin JP, Agostini C, Bachelot T, Guastalla JP, Pivot X, Martin JP, Bajard A, Ray-Coquard I

Abstract

Chemotherapy induced nausea and vomiting (CINV) remains a major problem that seriously impairs the quality of life (QoL) in cancer patients receiving chemotherapy regimens. Complementary medicines, including homeopathy, are used by many patients with cancer, usually alongside with conventional treatment. A randomized, placebo-controlled Phase III study was conducted to evaluate the efficacy of a complex homeopathic medicine, Cocculine, in the control of CINV in non-metastatic breast cancer patients treated by standard chemotherapy regimens.

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 4%
United States 1 4%
Unknown 24 92%

Demographic breakdown

Readers by professional status Count As %
Other 3 12%
Researcher 1 4%
Unknown 22 85%
Readers by discipline Count As %
Medicine 17 65%
Biological Sciences 6 23%
Psychology 1 4%
Unknown 2 8%

Score in context

This research output has an Altmetric score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This score was calculated when the research output was last mentioned on 29 October 2014.
All research outputs
#169,655
of 4,693,136 outputs
Outputs from BMC Cancer
#21
of 2,597 outputs
Outputs of similar age
#13,380
of 286,885 outputs
Outputs of similar age from BMC Cancer
#1
of 101 outputs
Altmetric has tracked 4,693,136 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,597 research outputs from this source. They receive a mean score of 2.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this score to the 286,885 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.